A case report reveals distinct treatments for IgG4 MALT lymphoma and IgG4-related disease in an individual.
A 60-year-old Japanese man developed a protruding right eye. He underwent a magnetic resonance imaging (MRI) scan, which revealed a right orbital mass. The serum immunoglobulin G4 (IgG4) level was elevated and IgG4+ plasma cells were observed in biopsy specimens of the mass. The result of biopsy and Southern blot analysis revealed that the mass was caused by IgG4+ extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). He received a total of 36 Gy of radiation therapy, and the mass disappeared. Five years later, he developed a protruding left eye. The MRI scan at that time revealed a left orbital mass. Biopsy revealed findings of IgG4–related disease (IgG4-RD) in the left orbital mass, but no findings of MALT lymphoma. He has been followed up without glucocorticoid treatment. Here, we report a patient who developed IgG4+ MALT lymphoma in the right orbital mass and IgG4–related ophthalmic disease (IgG4-ROD) in the left orbital mass. Because the treatment strategy for IgG4-ROD and malignant lymphoma is completely different, we emphasize the need for biopsy.
No takes yet. Share an insight, caveat, or question.
Araki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: